Biopharmaceutical Market Forecast: 8.82% CAGR from 2025 to 2032
The global biopharmaceutical market was valued at USD 486.15 billion in 2023 and is projected to reach USD 1,039.14 billion by 2032, growing at a CAGR of 8.82% from 2025 to 2032. Market growth is driven by the rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, along with increasing demand for innovative biologic treatments. Advancements in personalized medicine, monoclonal antibodies, gene therapy, and regulatory approvals are further accelerating the development of new, targeted therapies.